FDA Issues Emergency Use Authorization for First COVID-19 Vaccine
December 12, 2020
Silver Spring, MD – The U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older.
The emergency use authorization allows the Pfizer-BioNTech COVID-19 Vaccine to be distributed in the United States.
FDA issues Emergency Use Authorization for Pfizer-BioNTech COVID-19 Vaccine.
Coronavirus (COVID-19) Update: FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines
July 4, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has taken important action to help facilitate the timely development of safe and effective vaccines to prevent COVID-19 Coronavirus by providing guidance with recommendations for those developing COVID-19 Coronavirus vaccines for the ultimate purpose of licensure.
Coronavirus.
